Acasti Pharma reported $459K in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Addus HomeCare USD 18.04M 4M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
Cassava Sciences USD 39.19M 2.46M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Option Care Health USD 639.77M 94.75M Jun/2026
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025